missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Description
- Capto Q ImpRes is a strong anion exchange BioProcess medium, designed to meet the demands of modern large-scale manufacturers for fast, efficient, and cost-effective intermediate and polishing protein purification.
- 10 cm bed height of HiScreen columns is designed to allow method optimization and parameter screening.
- Easily connected in series to achieve 20 cm bed height.
- Small bed volume gives fast results and minimal sample/buffer consumption.
- Reproducible results, scalable to BioProcess columns packed with the same chromatography media using the same linear fluid velocity.
Specifications
Specifications
| Bed Volume | 4.7 |
| Diameter (Metric) Inner | 7.7 mm |
| Flow Rate | 100 to 300 cm/h |
| Max. Pressure | 4 bar [0.4 MPa] (59 psi) |
| Content And Storage | 4° to 30°C, in 20% Ethanol |
| Column Type | Ion Exchange Column |
| For Use With (Application) | Ion Exchange Chromatography |
Safety and Handling
Product Identifier
- HiScreen Capto Q ImpRes, 4.7 ml
- Warning
- Flammable liquid Category 3
- H226-Flammable liquid and vapour.
- P241-Use explosion-proof electrical/ventilating/lighting/ equipment.
- P260-Do not breathe dust/fume/gas/mist/vapours/spray.
- P280-Wear protective gloves/protective clothing/eye protection/face protection.
- P305+P351+P338-IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
- P405-Store locked up.
- P501b-Dispose of contents/container in accordance with local/regional/national/international regulations.
- MIXTURE LIST-Contain: ethanol
- UNKNOWN ACUTE-16.5 per cent of the mixture consists of component(s) of unknown acute toxicity.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?